Abstract
During 2016-2023, among 21,195 US patients who tested positive for Candida auris colonization, 6.9% were subsequently found to have a positive clinical specimen (2.8% from blood). Strategies are needed to prevent invasive C. auris infections among patients with colonization (e.g., through patient decolonization).